1.
Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis. Biomol Biomed [Internet]. 2015 May 25 [cited 2025 Sep. 8];15(2):73-7. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/387